CERA

Science and Research

ONL1204(GA): A Phase 1b Multicenter, Randomized, Single-dose Study of the Safety and Tolerability of ONL1204 Ophthalmic solution in patients with Geographic Atrophy (GA) associated with Age-related Macular Degeneration (AMD).

Overview

  • Principal Investigator
Professor Robyn Guymer AM